Enhanced Repression by HESX1 as a Cause of Hypopituitarism and Septooptic Dysplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 10, 2003, Pages 4832-4839

  Cohen, Ronald N ^a,c   Cohen, Laurie E ^b   Botero, Diego ^b   Yu, Christine ^a   Sagar, Angela ^a   Jurkiewicz, Magdalena ^a   Radovick, Sally ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Section of Endocrinology Diabetes and Metabolism   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HESX 1; TRANSCRIPTION FACTOR PROP 1; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; DNA BINDING; GENE ACTIVITY; GENE MUTATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOPHYSIS; HYPOPHYSIS DISEASE; HYPOPITUITARISM; INFANT; MALE; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; PRIORITY JOURNAL; SEPTOOPTIC DYSPLASIA;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; HYPOPITUITARISM; PHENOTYPE; POINT MUTATION; SEPTO-OPTIC DYSPLASIA; TRANSCRIPTION, GENETIC;

EID: 0242383356     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021868     Document Type: Article

References (30)

1. Rosenfeld MG, Briata P, Dasen J, Gleiberman AS, Kioussi C, Lin C, O'Connell SM, Ryan A, Szeto DP, Treier M 2000 Multistep signaling and transcriptional requirements for pituitary organogenesis in vivo. Recent Prog Horm Res 55:1-13; discussion 13-14
2. Cohen LE, Radovick S 2002 Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23:431-442
3. Rosenfeld MG 1991 POU-domain transcription factors: pou-er-ful developmental regulators. Genes Dev 5:897-907
4. Achermann JC, Weiss J, Lee EJ, Jameson JL 2001 Inherited disorders of the gonadotropin hormones. Mol Cell Endocrinol 179:89-96
5. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE 1992 A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257:1115-1118
6. Cohen LE, Wondisford FE, Salvatoni A, Maghnie M, Brucker-Davis F, Weintraub BD, Radovick S 1995 A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J Clin Endocrinol Metab 80:679-684
7. Ohta K, Nobukuni Y, Mitsubuchi H, Fujimoto S, Matsuo N, Inagaki H, Endo F, Matsuda I 1992 Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 189:851-855
8. Fofanova OV, Takamura N, Kinoshita E, Parks JS, Brown MR, Peterkova VA, Evgrafov OV, Goncharov NP, Bulatov AA, Dedov II, Yamashita S 1998 A mutational hot spot in the Prop-1 gene in Russian children with combined pituitary hormone deficiency. Pituitary 1:45-49
9. Fof anova O, Takamura N, Kinoshita E, Parks JS, Brown MR, Peterkova VA, Evgrafov OV, Goncharov NP, Bulatov AA, Dedov II, Yamashita S 1998 Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 83:2601-2604
10. Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips 3rd JA, Rosenfeld MG 1998 Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 18:147-149
11. Cogan JD, Wu W, Phillips 3rd JA, Arnhold IJ, Agapito A, Fofanova OV, Osorio MG, Bircan I, Moreno A, Mendonca BB 1998 The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 83:3346-3349
12. Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, Arnhold IJ 1999 Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. J Clin Endocrinol Metab 84:942-945
13. Rosenbloom AL, Almonte AS, Brown MR, Fisher DA, Baumbach L, Parks JS 1999 Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab 84:50-57
14. Parks JS, Brown MR, Hurley DL, Phelps CJ, Wajnrajch MP 1999 Heritable disorders of pituitary development. J Clin Endocrinol Metab 84:4362-4370
15. Pernasetti F, Toledo SP, Vasilyev W, Hayashida CY, Cogan JD, Ferrari C, Lourenco DM, Mellon PL 2000 Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. J Clin Endocrinol Metab 85:390-397
16. Agarwal G, Bhatia V, Cook S, Thomas PQ 2000 Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J Clin Endocrinol Metab 85:4556-4561
17. Osorio MG, Kopp P, Marui S, Latronico AC, Mendonca BB, Arnhold IJ 2000 Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomain of PROP-1. J Clin Endocrinol Metab 85:2779-2785
18. Hermesz E, Mackem S, Mahon KA 1996 Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development 122:41-52
19. Dasen JS, Barbera JP, Herman TS, Connell SO, Olson L, Ju B, Tollkuhn J, Baek SH, Rose DW, Rosenfeld MG 2001 Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev 15:3193-207
20. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG 1996 Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384:327-333
21. Xu L, Lavinsky RM, Dasen JS, Flynn SE, Mclnerney EM, Mullen TM, Heinzel T, Szeto D, Korzus E, Kurokawa R, Aggarwal AK, Rose DW, Glass CK, Rosenfeld MG 1998 Signal-specific co-activator domain requirements for Pit-1 activation. Nature 395:301-306
22. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
23. Thomas PQ, Dattani MT, Brickman JM, McNay D, Warne G, Zacharin M, Cameron F, Hurst J, Woods K, Dunger D, Stanhope R, Forrest S, Robinson IC, Beddington RS 2001 Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 10:39-45
24. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC, Krauss S, Beddington RS, Robinson IC 1998 Mutations in the homeobox gene HESX1/ Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19:125-133
25. Brickman JM, Clements M, Tyrell R, McNay D, Woods K, Warner J, Stewart A, Beddington RS, Dattani M 2001 Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 128:5189-5199
26. Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE, Hollenberg AN 2001 The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol Endocrinol 15:1049-1061
27. Zanger K, Cohen LE, Hashimoto K, Radovick S, Wondisford FE 1999 A novel mechanism for cyclic adenosine 3′, 5′-monophosphate regulation of gene expression by CREB-binding protein. Mol Endocrinol 13:268-275
28. Zanger K, Radovick S, Wondisford FE 2001 CREB binding protein recruitment to the transcription complex requires growth factor-dependent phosphorylation of its GF box. Mol Cell 7:551-558
29. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, Carriere C, Rose DW, Hooshmand F, Aggarwal AK, Rosenfeld MG 2000 Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science 290:1127-1131
30. Quirk J, Brown P 2002 Hesx1 homeodomain protein represses transcription as a monomer and antagonises transactivation of specific sites as a homodimer. J Mol Endocrinol 28:193-205